LUPINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 3.863
AS - Asia 1.695
EU - Europa 1.504
SA - Sud America 232
AF - Africa 24
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.323
Nazione #
US - Stati Uniti d'America 3.781
SG - Singapore 701
CN - Cina 504
IT - Italia 325
DE - Germania 288
PL - Polonia 270
BR - Brasile 199
FI - Finlandia 151
HK - Hong Kong 146
TR - Turchia 125
GB - Regno Unito 124
UA - Ucraina 97
VN - Vietnam 84
SE - Svezia 62
ID - Indonesia 40
CA - Canada 39
RU - Federazione Russa 39
MX - Messico 35
BE - Belgio 30
IN - India 22
NL - Olanda 20
RO - Romania 17
AT - Austria 16
CZ - Repubblica Ceca 16
FR - Francia 16
ZA - Sudafrica 14
AR - Argentina 13
BD - Bangladesh 13
JP - Giappone 10
ES - Italia 9
IQ - Iraq 8
LT - Lituania 8
IR - Iran 7
EC - Ecuador 6
IE - Irlanda 6
KZ - Kazakistan 5
CL - Cile 4
PE - Perù 4
AU - Australia 3
CO - Colombia 3
DZ - Algeria 3
PK - Pakistan 3
SA - Arabia Saudita 3
TW - Taiwan 3
UZ - Uzbekistan 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
JO - Giordania 2
LK - Sri Lanka 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MQ - Martinica 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TL - Timor Orientale 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.323
Città #
Ashburn 440
Fairfield 430
Singapore 362
Woodbridge 349
Warsaw 268
Houston 225
Ann Arbor 222
Chandler 203
Beijing 201
Seattle 176
Munich 171
Santa Clara 170
Hong Kong 146
Cambridge 135
Wilmington 128
Jacksonville 125
Ferrara 113
Dallas 103
New York 97
Helsinki 75
Izmir 66
Los Angeles 63
Turku 47
Milan 46
Nanjing 45
Shanghai 42
Princeton 37
Jakarta 36
Brussels 30
San Diego 27
Ho Chi Minh City 25
Mexico City 25
Boardman 23
London 23
Nanchang 21
Bremen 19
Buffalo 19
Chicago 19
São Paulo 19
Tianjin 19
Addison 17
Timisoara 17
Falls Church 16
Phoenix 16
Hanoi 15
Brooklyn 14
Rome 14
Brno 13
Denver 13
Dong Ket 13
Shenyang 13
Toronto 13
Changsha 12
Johannesburg 12
Orem 12
The Dalles 12
Nuremberg 11
Bologna 10
Boston 10
Montreal 10
Redwood City 10
Stockholm 10
Tokyo 10
Atlanta 9
Dearborn 9
Hebei 9
Poplar 9
Amsterdam 8
Columbus 8
Kunming 8
Manchester 8
Moscow 8
Rio de Janeiro 8
San Francisco 8
Chennai 7
Council Bluffs 7
Frankfurt am Main 7
Washington 7
Auburn Hills 6
Dublin 6
Falkenstein 6
Hefei 6
Jiaxing 6
Mountain View 6
Salt Lake City 6
Vienna 6
Ankara 5
Brasília 5
Ferrara di Monte Baldo 5
Guarulhos 5
Haiphong 5
Naples 5
Ningbo 5
Philadelphia 5
Tampa 5
Belo Horizonte 4
Cagliari 4
Des Moines 4
Guangzhou 4
Hangzhou 4
Totale 5.316
Nome #
Absolute quantification of cell-free microRNAs in cancer patients 273
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 262
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 260
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 249
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 247
Ruolo del miR-221 nella tumorigenesi epatica 237
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 233
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 224
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 217
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 216
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 212
Circulating non-coding RNA as biomarkers in colorectal cancer 205
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 205
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 204
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 202
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 201
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 187
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 186
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 181
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 181
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 177
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 177
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 171
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 164
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 162
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 160
Oncogenic role of miR-483-3p at the IGF2/483 locus 148
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 145
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 139
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 139
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 136
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 134
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 129
Mutated beta-catenin evades a microRNA-dependent regulatory loop 129
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 128
The importance of microRNAs in RAS oncogenic activation in human cancer 125
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 115
null 89
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 88
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 88
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing 81
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy 80
null 77
null 63
Totale 7.426
Categoria #
all - tutte 34.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.495
Totale 35.859


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021505 0 0 0 0 0 80 33 66 24 147 87 68
2021/2022451 23 30 30 23 23 23 45 24 16 33 53 128
2022/2023474 48 41 29 67 66 72 35 31 52 2 17 14
2023/2024332 28 36 11 5 31 85 16 28 7 8 5 72
2024/20251.520 35 35 95 78 147 171 93 69 309 114 183 191
2025/20261.741 389 135 267 394 502 54 0 0 0 0 0 0
Totale 7.426